I’m not sure what you mean by “ixarola.” Xarelto is rivaroxaban. Do you mean rivaroxaban versus apixaban (brand Eliquis) or rivaroxaban versus another DOAC (edoxaban, dabigatran, etc.)? If you can confirm which second drug you meant, I can give a precise side-by-side.
In the meantime, here’s a quick comparison if you’re asking about rivaroxaban vs apixaban (the two most commonly compared DOACs):
- Drug class and mechanism
- Both are direct oral anticoagulants that inhibit factor Xa to prevent blood clots.
- Common uses
- Atrial fibrillation (nonvalvular): reduce stroke risk.
- Treatment of DVT and PE.
- Prophylaxis after hip or knee replacement (orthopedic surgery).
- Dosing patterns
- Rivaroxaban (Xarelto): often once daily dosing for AF (20 mg with the evening meal); for DVT/PE treatment, 15 mg twice daily for 21 days, then 20 mg once daily with food.
- Apixaban (Eliquis): usually twice daily (e.g., 5 mg twice daily for AF; 10 mg twice daily for 7 days then 5 mg twice daily for DVT/PE treatment after the initial period; orthopedic prophylaxis often 2.5 mg twice daily for a set period).
- Food effects
- Rivaroxaban: higher-dose tablets (like 15 mg and 20 mg) must be taken with food.
- Apixaban: no specific food requirement.
- Renal and hepatic considerations
- Both require caution with kidney disease; dosing can change depending on renal function and other factors.
- Both have hepatic considerations; avoid or use with caution in significant liver disease.
- Bleeding risk and safety
- Both can cause major bleeding. Some differences have been noted in trials:
- Intracranial bleeding rates are generally similar or sometimes lower with apixaban.
- GI bleeding risk can be higher with rivaroxaban compared to apixaban in some settings.
- Reversal: Andexanet alfa is approved as a reversal agent for both rivaroxaban and apixaban in many places; PCCs may be used in emergencies when andexanet isn’t available.
- Dosing convenience and adherence
- Rivaroxaban is often once daily (some doses twice daily, depending on indication).
- Apixaban is usually twice daily, which can matter for adherence.
- Other practical notes
- Both do not require routine INR monitoring (unlike warfarin).
- If you need to switch between them, do so under medical supervision to manage timing and bleeding risk.
- Always consider drug interactions (antibiotics, antifungals, antifolate drugs, certain antiplatelets, NSAIDs, etc.) and kidney/hepatic function.
If you meant a different drug for “ixarola,” please tell me which one, and I’ll tailor the comparison. And if you’re considering a switch or starting one of these meds, share a bit about your condition, kidney function, liver function, age/weight, and current meds so I can give more specific guidance. But for medical decisions, always follow your clinician’s advice.